Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 518 followers
Latest posts
Last updated 3 days ago
Roche’s Vabysmo demonstrates sustained two-year results in a difficult-to-treat form of neovascular age-related macular degeneration (nAMD)
3 days ago
The SALWEEN study showed significant improvements in vision and retinal health1 More...
Roche’s US subsidiary Genentech announces manufacturing expansion in the United States
11 days ago
New facility in Hillsboro, Oregon for the assembly of injectable medicines and...
CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)
about 1 month ago
Susvimo is the first and only continuous delivery treatment that offers an...
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
about 1 month ago
Group sales were +6% at constant exchange rates (CER)1, -2% when reported...
FDA grants Priority Review to Roche’s Gazyva/Gazyvaro for adults with primary membranous nephropathy
about 2 months ago
Priority Review decision is based on phase III MAJESTY results, where Gazyva/Gazyvaro...
Roche introduces cobas Hepatitis D Virus (HDV) test, the first fully automated diagnostic solution to identify the most severe form of viral hepatitis
about 2 months ago
The new test enables clinicians to reliably diagnose HDV and monitor patients’...
Roche receives CE Mark for blood test to identify tuberculosis infection
about 2 months ago
The Elecsys IGRA TB test expands global access to tuberculosis infection testing...
Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at AAIC
about 2 months ago
Five oral presentations in a Featured Research Session will highlight trontinemab, including...
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer
2 months ago
Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated...
FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
2 months ago
The filing application is based on improvements seen across key efficacy endpoints...
Roche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform
2 months ago
AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost...
FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma
2 months ago
Filing acceptance based on data from the phase III SUNMO study where...